Anti-vascular endothelial growth factor monotherapy in the treatment of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.

@article{Cho2013AntivascularEG,
  title={Anti-vascular endothelial growth factor monotherapy in the treatment of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.},
  author={Han Joo Cho and Kyung Min Koh and Hyoung Seok Kim and Tae Gon Lee and Chul Gu Kim and Jong Woo Kim},
  journal={American journal of ophthalmology},
  year={2013},
  volume={156 3},
  pages={
          524-531.e1
        }
}
PURPOSE To evaluate the effect of intravitreal anti-vascular endothelial growth factor (VEGF) injections on submacular hemorrhage secondary to polypoidal choroidal vasculopathy. DESIGN Retrospective, interventional case series. METHODS Twenty-seven eyes from 27 polypoidal choroidal vasculopathy patients with submacular hemorrhage involving the fovea… CONTINUE READING